Of them, CDKN3 have been demonstrated to promote the malignant progression of cervical cancer,42 regulate cisplatin resistance to colorectal cancer43 and promote cell proliferation and invasion in human ovarian cancer.44 This evidence concerns the gene CDKN3 and cervical carcinoma.